Pentoxifylline
Spécifications
6493-05-6Numéro CAS
229-374-5Numéro CE
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dioneNom IUPAC
C13H18N4O3Formule chimique
278.31 g/molMasse molaire
pentoxifylline; 6493-05-6; Trental; Oxpentifylline; Pentoxil; Pentoxyphylline; Pentoxiphyllin; 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-; 3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione; 1-(5-Oxohexyl)theobromine; BL 191; BL-191; Pentoxifilina; Oxypentifylline; Pentoxifyllinum; DTXSID7023437; SD6QCT3TSU; NSC637086; 3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione; NSC-637086; NSC-758481; 1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion; C04AD03; DTXCID803437; BL191; pentoxifillina; Neotren mr; Trental 100; Trental 400; RefChem:57078; 229-374-5; Pentoxifyllin; Torental; Vazofirin; 3,7-Dimethyl-1-(5-oxohexyl)xanthine; Dimethyloxohexylxanthine; Pentoxiphyllium; Pentoxyfylline; Pentoxiphylline; Rentylin; 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione; 3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione; Pentoxyphyllin; 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione; Pentoxyfilline; Pentoxyifylline; 1-(5-Oxohexyl)-3,7-dimethylxanthine; MFCD00063379; Theobromine, 1-(5-oxohexyl)-; CHEMBL628; NSC 637086; 3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione; MLS000079026; Azupentat; EHT 0202; NCGC00015801-02; Durapental; SMR000035998; PNX; Hemovas; Ralofect; Vasofirin; Ikomio; Agapurin Retard; Pentoxifilina [INN-Spanish]; Pentoxifyllinum [INN-Latin]; Pentoxil (TN); Trental (TN); CAS-6493-05-6; EHT0201; SR-01000075641; 3,7-Dimethyl-1-(5-oxohexyl)xantine; 3,7-Dimethyl-1-(5-oxohexyl) xantine; Pentopak; Azupentat;; CCRIS 6832; Pentoflux;; Agapurin;; Torental;; Pentoxifylline (JAN/USP/INN); 3arr; 3aru; 3tvx; EHT-201; Pentoxifylline CRS; PTX;Oxpentifylline; EHT-0201; Prestwick_608; EINECS 229-374-5; PTXF; BRN 0558929; Spectrum_001444; 2a3c; UNII-SD6QCT3TSU; Opera_ID_1800; Prestwick0_000196; Prestwick1_000196; Prestwick2_000196; Prestwick3_000196; Spectrum2_001181; Spectrum3_001820; Spectrum4_000227; Spectrum5_001161; Lopac-P-1784; Pentoxifylline (Standard); P 1784; PENTOXIFYLLINE [MI]; PENTOXIFYLLINE [INN]; PENTOXIFYLLINE [JAN]; Lopac0_000936; SCHEMBL34039; 1-(5-Oxohexyl)-theobromine; BSPBio_000151; BSPBio_003439; KBioGR_000893; KBioSS_001924; PENTOXIFYLLINE [USAN]; MLS000758298; MLS001201764; MLS001424051; BIDD:GT0174; DivK1c_000729; PENTOXIFYLLINE [VANDF]; SPECTRUM1503611; SPBio_001221; SPBio_002072; PENTOXIFYLLINE [MART.]; BPBio1_000167; CHEBI:7986; GTPL7095; orb1224349; orb1310971; PENTOXIFYLLINE [USP-RS]; PENTOXIFYLLINE [WHO-DD]; BDBM10850; HMS502E11; HY-B0715R; KBio1_000729; KBio2_001924; KBio2_004492; KBio2_007060; KBio3_002942; MSK9064; NINDS_000729; GLXC-15427; HMS1568H13; HMS1922E16; HMS2051N06; HMS2090H13; HMS2093G21; HMS2095H13; HMS2235C16; HMS3262L14; HMS3370D09; HMS3393N06; HMS3712H13; HMS5083E13; Pharmakon1600-01503611; Pentoxifylline - Bio-X trade mark; HY-B0715; PENTOXIFYLLINE [ORANGE BOOK]; Tox21_110223; Tox21_500936; BBL016497; CCG-36382; EBC-12154; NSC758481; PDSP1_001015; PDSP2_000999; PENTOXIFYLLINE [EP MONOGRAPH]; STK177321; PENTOXIFYLLINE [USP MONOGRAPH]; AKOS000541484; Tox21_110223_1; AC-8381; DB00806; FP26823; LP00936; NC00255; SDCCGSBI-0050910.P004; 3,7-dimethyl-1-(5-oxohexyl)-xanthine; CAS-1677687; IDI1_000729; NCGC00015801-01; NCGC00015801-03; NCGC00015801-04; NCGC00015801-05; NCGC00015801-06; NCGC00015801-07; NCGC00015801-08; NCGC00015801-09; NCGC00015801-10; NCGC00015801-12; NCGC00015801-15; NCGC00015801-17; NCGC00015801-21; NCGC00067069-02; NCGC00067069-03; NCGC00067069-04; NCGC00067069-05; NCGC00178062-01; NCGC00178062-02; NCGC00261621-01; AS-13662; BP166188; Pentoxifylline [USAN:USP:INN:BAN:JAN]; SY055216; SBI-0050910.P003; 1-(5-oxohexyl)theobromine (pentoxifylline); AB00052363; EU-0100936; NS00010010; P2050; S4345; ST50242554; SW196777-4; C07424; D00501; D70138; M02258; AB00052363-17; AB00052363_18; AB00052363_21; 5-26-14-00081 (Beilstein Handbook Reference); EN300-18527828; Q416331; 3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione; SR-01000075641-1; SR-01000075641-4; SR-01000075641-7; SR-01000075641-9; BRD-K57569181-001-05-1; BRD-K57569181-001-16-8; BRD-K57569181-001-26-7; BRD-K57569181-001-27-5; Z1741982628; 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydropurine-2,6-dione; 3,7-dimethyl-1-(5-oxohexyl)-1,3,7-trihydropurine-2,6-dione; 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione #; PxSynonymes
Produits contenant Pentoxifylline
씨엠지펜톡시필린서방정400mg(펜톡시필린)명인펜톡시필린서방정(펜톡시필린)(수출용)메조톡실주(펜톡시필린)(수출용)카펜탈주(펜톡시필린)(수출용)트렌탈서방정400(펜톡시필린)PENTOXIFILINA VIR 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGPENTOXIFILINA SEJMET 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGPENTOXIFILINA ALTER 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGHEMOVAS 600 MG COMPRIMIDOS DE LIBERACION PROLONGADAHEMOVAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADAHEMOVAS 300 MG SOLUCION PARA PERFUSIONELORGAN 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA
Page 1 sur 3
Entreprises vendant Pentoxifylline
Page 1 sur 3